S. Schroder, K. Bluml, C. Dees, and M. Lohse. FEBS Lett, 401 (2-3):
243-6(January 1997)Schroder, S Bluml, K Dees, C Lohse, M J Research Support, Non-U.S.
Gov't Netherlands FEBS letters FEBS Lett. 1997 Jan 20;401(2-3):243-6..
A. Chruscinski, M. Brede, L. Meinel, M. Lohse, B. Kobilka, and L. Hein. Mol Pharmacol, 60 (5):
955-62(November 2001)Chruscinski, A Brede, M E Meinel, L Lohse, M J Kobilka, B K Hein,
L Research Support, Non-U.S. Gov't United States Molecular pharmacology
Mol Pharmacol. 2001 Nov;60(5):955-62..
K. Klotz, H. Vogt, and H. Tawfik-Schlieper. Naunyn Schmiedebergs Arch Pharmacol, 343 (2):
196-201(February 1991)Klotz, K N Vogt, H Tawfik-Schlieper, H Comparative Study Germany
Naunyn-Schmiedeberg's archives of pharmacology Naunyn Schmiedebergs
Arch Pharmacol. 1991 Feb;343(2):196-201..
M. Lohse, K. Bluml, S. Danner, and C. Krasel. Biochem Soc Trans, 24 (4):
975-80(November 1996)Lohse, M J Bluml, K Danner, S Krasel, C Review England Biochemical
Society transactions Biochem Soc Trans. 1996 Nov;24(4):975-80..